fuzeon造句

• Fuzeon, which is injected, also will typically be taken with other drugs.
• Fuzeon's high cost is due to its complexity, the company says.
• Analysts say Fuzeon's pricing suggests Roche could turn a profit in three years.
• Cash-strapped AIDS assistance programs are already worried they might not be able to afford Fuzeon.
• Fuzeon is a very difficult drug to make, requiring 106 steps to produce the active substance.
• Roche said Fuzeon represents " the first significant breakthrough in HIV therapy since 1996 ."
• The companies knew Fuzeon had promise but couldn't know how it would perform in large trials.
• Fuzeon is the most clinically advanced agent of the fusion inhibitors, a completely new class of drugs.
• Last August, Fuzeon won a priority, six-month review from the Food and Drug Administration.
• The manufacturing process for Fuzeon is very complicated, requiring 44 ingredients, about three times the norm.
• Recently, inhibitors derived from HR2 such as Fuzeon, but these have not entered the clinic yet.
• Roche and Trimeris also have said they may not be able to make enough Fuzeon to meet initial demand.
• Fuzeon is a " fusion inhibitor, " designed to block HIV from entering healthy blood cells.
• Fuzeon was discovered by two researchers at Duke University, Dani Bolognesi and Tom Matthews, who then founded Trimeris.
• Unlike other AIDS drugs, Fuzeon blocks the HIV virus, the cause of AIDS, from entering immune cells.
• The companies said they hope to put Fuzeon on the market " from the first quarter next year ."
• The issue is the high price tag for the drug, called Fuzeon _ about $ 20, 000 a year.
• "We don't think we can add Fuzeon ( to our drug list ) without cutting something else.
• Manufacturing constraints mean only between 12, 000 to 15, 000 patients worldwide will have access to Fuzeon this year.
• The company has an agreement with Roche Laboratories for pricing discounts in exchange for providing blind patient data on Fuzeon medication.